DePuy Orthopaedics acquires BioMedical Enterprises: 6 things to know

Written by Anuja Vaidya | May 07, 2016 | Print  | Email

DePuy Orthopaedics, part of the DePuy Synthes Companies of Johnson & Johnson, acquired BioMedical Enterprises.

Here are six things to know:

 

1. BioMedical Enterprises manufactures Nitinol orthopedic implants for small bone fixation. Nitinol is a nickel-titanium alloy that provides dynamic continuous active compression.

 

2. The implants are indicated for treatment of bunions, hammertoes and other foot and ankle deformities as well as hand and wrist deformities.

 

3. The implants come ready-to-use on a sterilized, pre-loaded, disposable insertion tool.

 

4. The acquisition reinforces Johnson & Johnson Medical Device's focus on strengthening DePuy Synthes' portfolio for elective extremity procedures.

 

5. DePuy Synthes focuses on the foot and ankle as well as hand and wrist markets for bone fixation in trauma.

 

6. England Securities, LLC represented the seller, BioMedical Enterprises, in the transaction.

 

More articles on devices:
FDA clears First Ray's Stealth Staple System — 5 highlights
Medtronic names Karen Parkhill EVP, CFO: 5 key notes
Siemens, Ziehm, GE, Hologic, OrthoScan & Medtronic: 26 O-arm & C-arm systems

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.